Dr. Baughman is a biotechnology expert with over 40 years of experience in the industry. She has been consulting for over 14 years specializing in Pharmacokinetics and Drug Metabolism, GLP and GCP compliance, and regulatory submissions.
Prior to consulting, Sharon was Executive Director in Global Research and Development Compliance and Director of Pharmacokinetics and Drug Metabolism, for therapeutic proteins and small molecules, at Amgen. Prior to joining Amgen, Sharon was Ass. Director and Scientist at Genentech Inc. where she worked on the development of many protein therapeutics, including Herceptin®, Rituxan®, Avastin®, Protropin®, Nutropin® and Pulmozyme®.
Her experience includes performing research and development of protein therapeutics throughout North America, Asia, Australia, and Europe. She has actively been involved with the FDA Critical Path Initiative and the development of biomarkers to improve the drug development timeline.
Dr. Baughman received her Ph.D. in Chemistry from Rice University and a BS in Chemistry from the University of New Orleans.
